Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RAPT - RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria Transcript

RAPT - RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria Transcript

RAPT Therapeutics Inc.

2025-10-20 17:05:38 ET

RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT...

For further details see:

RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria Transcript

Stock Information
Company Name: RAPT Therapeutics Inc.
Stock Symbol: RAPT
Market: NASDAQ
Website: rapt.com
Menu
RAPT RAPT Quote RAPT Short RAPT News RAPT Articles RAPT Message Board
Get RAPT Alerts

News, Short Squeeze, Breakout and More Instantly...